Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,486 papers from all fields of science
Search
Sign In
Create Free Account
tedizolid
Known as:
torezolid
, 3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
, 2-Oxazolidinone, 3-(3-Fluoro-4-(6-(2-Methyl-2H-Tetrazol-5-yl)-3-Pyridinyl)Phenyl)-5-(Hydroxymethyl)-, (5R)-
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Broader (3)
Anti-Bacterial Agents
Oxazolidinones
Tetrazoles
Bacterial Infections
Breast Cancer Resistance Protein Inhibitors [MoA]
Tedizolid:Susc:Pt:Isolate:OrdQn
Tedizolid:Susc:Pt:Isolate:OrdQn:Agar diffusion
Expand
Narrower (3)
Sivextro
TR 700
tedizolid phosphate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects
M. Seki
,
Yasuhiro Kamioka
,
+6 authors
Yuji Watanabe
The American journal of case reports
2020
Corpus ID: 219471449
Patient: Female, 38-year-old Final Diagnosis: Peritonitis Symptoms: Abdominal and/or epigastric pain Medication:— Clinical…
Expand
2019
2019
In Vitro Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant Staphylococcus aureus (2014-2015) in the United…
M. Pfaller
,
H. Sader
,
P. Rhomberg
,
R. Flamm
,
R. Mendes
Microbial Drug Resistance
2019
Corpus ID: 59413159
Tedizolid activity was compared with other agents with oral and intravenous formulations against community-acquired methicillin…
Expand
2017
2017
Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis
Brian J. Werth
Journal of Antimicrobial Chemotherapy
2017
Corpus ID: 3799220
Objectives Tedizolid is an orally bioavailable oxazolidinone with once-daily dosing and broad-spectrum Gram-positive activity…
Expand
Review
2017
Review
2017
Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin
Rose M. Kohinke
,
A. Pakyz
Current Infectious Disease Reports
2017
Corpus ID: 207333731
Purpose of ReviewVancomycin-resistant Enterococci (VRE) infections are problematic due to limited availability of anti-VRE agents…
Expand
2016
2016
Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis
Kyung-Hwa Park
,
K. Greenwood-Quaintance
,
A. Schuetz
,
J. Mandrekar
,
Robin Patel
Antimicrobial Agents and Chemotherapy
2016
Corpus ID: 31532656
ABSTRACT We developed a rat model of methicillin-resistant Staphylococcus epidermidis (MRSE) foreign body-associated…
Expand
2016
2016
A highly sensitive and efficient UPLC-MS/MS assay for rapid analysis of tedizolid (a novel oxazolidinone antibiotic) in plasma sample.
M. Iqbal
Biomedical chromotography
2016
Corpus ID: 46212334
Tedizolid (TDZ) is a novel oxazolidinone class antibiotic, indicated for the treatment of acute bacterial skin and skin structure…
Expand
2016
2016
Chiral separation of tedizolid using charge single isomer derivatives of cyclodextrins by capillary electrokinetic chromatography.
K. Michalska
,
Ewa Gruba
,
J. Cielecka‐Piontek
,
E. Bednarek
Journal of Pharmaceutical and Biomedical Analysis
2016
Corpus ID: 19837631
Review
2016
Review
2016
New agents approved for treatment of acute staphylococcal skin infections
J. Tatarkiewicz
,
A. Staniszewska
,
M. Bujalska-Zadrożny
Archives of medical science : AMS
2016
Corpus ID: 10219956
Vancomycin has been a predominant treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections for decades…
Expand
2016
2016
In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China
D. Biedenbach
,
S. Bouchillon
,
B. Johnson
,
J. Alder
,
D. Sahm
European Journal of Clinical Microbiology and…
2016
Corpus ID: 22815568
Tedizolid is an oxazolidinone with an antimicrobial in vitro potency advantage against Gram-positive bacterial pathogens compared…
Expand
Review
2014
Review
2014
New pharmacological treatments for methicillin-resistant Staphylococcus aureus infections
Stuart L Burke
,
W. Rose
Expert Opinion on Pharmacotherapy
2014
Corpus ID: 5451954
Introduction: Despite available treatment options for methicillin-resistant Staphylococcus aureus (MRSA), the morbidity and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE